Device General Surgery

Conmed Biliary

Payments companies reported to CMS as associated with Conmed Biliary. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$141Kassociated payments (2023-2025)
907clinicians with associated payments
1company reporting

By year

2023 $49K
2024 $42K
2025 $50K

Payments reported as associated with Conmed Biliary, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $116K
Internal Medicine $7,081
Physician Assistant $2,431
Pediatric Gastroenterology $1,934
Family $1,583
Nurse Practitioner $1,130

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Conmed Biliary

These are the largest totals companies reported as associated with Conmed Biliary. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Sandeep Patel San Antonio, TX Gastroenterology (Internal Medicine) $18,949.88
David Forcione Boston, MA Gastroenterology (Internal Medicine) $2,568.89
Justin Forde Gainesville, FL Gastroenterology (Internal Medicine) $1,770.55
Jianhua Tau Austin, TX Gastroenterology (Internal Medicine) $1,603.00
Jasmine Sinha Chicago, IL Gastroenterology (Internal Medicine) $1,268.11
Terrance Rodrigues Chicago, IL Gastroenterology (Internal Medicine) $1,004.13
Grace Kim Chicago, IL Gastroenterology (Internal Medicine) $1,001.19
Abdul Aadam Chicago, IL Gastroenterology (Internal Medicine) $986.72
Sammy Ho Bronx, NY Gastroenterology (Internal Medicine) $942.87
Rushikesh Shah Dallas, TX Gastroenterology (Internal Medicine) $938.05

Prescribed Conmed Biliary?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.